Nadia Krupp is a Respiratory physician affiliated with Riley Hospital for Children. OpenAlex indexes 51 publications with 393 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
705 Riley Hospital Dr
Roc 4270
Indianapolis, IN 462025109
Telephone
317-274-7208Provider last certified this registry record 6 Feb 2026.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Healthcare Solutions, Inc.Program year20251 payment
- Regeneron Healthcare Solutions, Inc.Program year20241 payment
- AstraZeneca Pharmaceuticals LPProgram year20239 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
100%Interleukin-5 Antagonist100%Nucala100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Factors Impacting Transition to Adult Care for Patients Seen in a Pediatric Severe Asthma Clinic
Journal of Allergy and Clinical Immunology
2026 - Timing of High-Risk Asthma Specialist Enrollment and Severe Asthma Exacerbations in Children
The Journal of Allergy and Clinical Immunology In Practice
2026 - Real-world effectiveness of asthma biologics by age of initiation and early-childhood risk factors
Annals of the American Thoracic Society
2026 - Epinephrine Prescription and Post-injection Monitoring Practices for Biologic Therapies in Pediatric Severe Asthma Clinics: A Multicenter Survey Analysis
American Journal of Respiratory and Critical Care Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Sharon Andreoli, MD
Riley Hospital for Children
David Dunn, MD
Riley Hospital for Children
Gregory Borschel, MD
Riley Hospital for Children
James Croop, MD, PhD
Riley Hospital for Children
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”